Interstitial Lung Disease (ILD) refers to a group of lung disorders characterized by inflammation and scarring (fibrosis) of the lung tissue, affecting the spaces around the air sacs (interstitium). This scarring causes the lungs to become stiff, making it difficult for oxygen to pass into the bloodstream, leading to progressive breathing difficulties. ILD can result from various causes, including autoimmune diseases, occupational exposure to dust or chemicals, infections, or may even be idiopathic (unknown cause), as seen in idiopathic pulmonary fibrosis (IPF).
Symptoms of ILD usually develop gradually and worsen over time. Early detection is crucial to managing the progression of the disease, improving symptoms, and enhancing quality of life. Our pulmonologist provides a comprehensive evaluation, which may include high-resolution CT scans, lung function tests, and, if needed, a lung biopsy, to diagnose the type of ILD and determine its cause accurately.
Treatment for ILD focuses on slowing the progression of the disease and relieving symptoms. This may involve corticosteroids or antifibrotic drugs, supplemental oxygen therapy, and pulmonary rehabilitation to improve lung function and overall health. Personalized care and ongoing monitoring are essential to managing ILD effectively, as the condition varies significantly from one patient to another.